ArticlePlant communications2026
Integrated multi-omics analyses reveal that p-coumaroyl-CoA 2'-hydroxylases act upstream of stilbene synthases to mediate oxyresveratrol biosynthesis in mulberry (Morus alba).
Article in Plant communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Recent Advances in Mulberry Processing and Drying Technologies: A Comprehensive Review.Foods (Basel, Switzerland) · 2026Review
- Oxyresveratrol Suppresses EGF-Induced AKT Phosphorylation and Reduces Cellular Fitness While Promoting Apoptosis in EGFR-Wild-Type Non-Small Cell Lung Cancer Cells Under EGF Stimulation.International journal of molecular sciences · 2026Article
- Recent Advances in Physiological and Biochemical Responses of Grapevines to Downy Mildew Infection.Plants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Oxyresveratrol is a bioactive stilbenoid with strong antioxidant, anti-inflammatory, and tyrosinase-inhibitory activities that accumulates in mulberry (Morus alba) tissues. Despite its importance, the biosynthetic origin of oxyresveratrol has remained unclear, with competing hypotheses proposing either hydroxylation of resveratrol or synthesis from a distinct precursor. Moreover, resveratrol and oxyresveratrol predominantly accumulate in non-renewable parts of mulberry trees, limiting their efficient extraction. To overcome these spatiotemporal constraints, we established cell suspension cultures from mulberry twigs and demonstrated that combined treatment with methyl jasmonate and methyl- or hydroxypropyl-β-cyclodextrins elicits high levels of both resveratrol and oxyresveratrol, which accumulate both intra- and extracellularly. Using this system, we investigated the molecular basis of oxyresveratrol biosynthesis in mulberry. We first improved the structural and functional annotation of the mulberry genome by integrating short- and long-read sequencing data derived from elicited cell suspension transcriptomes. By combining these resources with integrative transcriptomic, proteomic, and metabolomic analyses, we identified coordinated induction of multiple stilbene synthases (STSs) and a group of p-coumaroyl-CoA 2'-hydroxylases (C2'Hs) that were strongly co-expressed with resveratrol and oxyresveratrol accumulation. Functional validation in Nicotiana benthamiana, grapevine cell cultures, and in vitro enzyme assays demonstrated that C2'Hs catalyze the hydroxylation of p-coumaroyl-CoA upstream of the STS reaction, generating 2',4'-dihydroxycinnamoyl-CoA as an alternative substrate for STSs. These findings demonstrate that oxyresveratrol is produced via a biosynthetic pathway parallel to resveratrol formation rather than through post-synthetic hydroxylation. In addition, we provide genomic and transcriptomic resources within the context of jasmonate-mediated elicitation, facilitating the discovery of novel phenylpropanoid structural and regulatory genes in the Morus genus. Together, our work establishes a new biosynthetic paradigm for stilbenoid diversification in plants and delivers molecular tools and resources for the biotechnological production of oxyresveratrol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.